Skip to main content
Advertisement
Advertisement

TNXP

TNXP logo

Tonix Pharmaceuticals Holding Corp.

7.30
USD
Sponsored
+0.02
+0.27%
Oct 09, 16:00 UTC -4
Closed
exchange

After-Market

7.31

+0.01
+0.14%

TNXP Earnings Reports

Positive Surprise Ratio

TNXP beat 22 of 43 last estimates.

51%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$16.19M
/
-$2.55
Implied change from Q2 26 (Revenue/ EPS)
+19.52%
/
+4.51%
Implied change from Q3 25 (Revenue/ EPS)
+392.04%
/
-28.97%

Tonix Pharmaceuticals Holding Corp. earnings per share and revenue

On Aug 10, 2026, TNXP reported earnings of -2.44 USD per share (EPS) for Q2 26, beating the estimate of -2.75 USD, resulting in a 11.29% surprise. Revenue reached 13.54 million, compared to an expected 7.88 million, with a 71.94% difference. The market reacted with a +4.66% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -2.55 USD, with revenue projected to reach 16.19 million USD, implying an increase of 4.51% EPS, and increase of 19.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NanoViricides Inc.
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$0.10
Actual
-$0.10
Surprise
+1.96%
FAQ
For Q2 2026, Tonix Pharmaceuticals Holding Corp. reported EPS of -$2.44, beating estimates by 11.29%, and revenue of $13.54M, 71.94% above expectations.
The stock price moved up 4.66%, changed from $12.03 before the earnings release to $12.59 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 3 analysts, Tonix Pharmaceuticals Holding Corp. is expected to report EPS of -$2.55 and revenue of $16.19M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement